![Chris Chapman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chris Chapman
Corporate Officer/Principal at Dermavant Sciences Ltd.
Profile
Chris Chapman is currently the Chief Commercial Officer at Dermavant Sciences Ltd.
Prior to this, he attended Towson University for his undergraduate degree.
Chris Chapman active positions
Companies | Position | Start |
---|---|---|
Dermavant Sciences Ltd.
![]() Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 2020-01-21 |
Training of Chris Chapman
Towson University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Dermavant Sciences Ltd.
![]() Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Chris Chapman